Dr. Jeffrey Lieberman | Finanzwire

Basculer en Français

10336	Companies
214545	Keywords
144372	Articles
113640	Press releases

Headlines Articles Press releases Dr. Jeffrey Lieberman

Home
Companies
Dr. Jeffrey Lieberman

BRIEF

published on 02/21/2024 at 22:00, 2 years 2 months ago

Dr. Jeffrey Lieberman sheds light on the mysteries of schizophrenia on "The People's Pharmacy" show

Jeffrey A. Lieberman The People's Pharmacy Schizophrenia Early Treatment Mental Illness
PRESS RELEASE

published on 02/21/2024 at 22:00, 2 years 2 months ago

World-Leading Schizophrenia Expert Dr. Jeffrey A. Lieberman Unravels the Mysteries of Schizophrenia on The People’s Pharmacy
Leading expert Dr. Jeffrey Lieberman discusses groundbreaking research on schizophrenia, early intervention, and prevention on The People's Pharmacy podcast

Schizophrenia Dr. Jeffrey Lieberman Early Intervention Prevention The People's Pharmacy Podcast
PRESS RELEASE

published on 01/29/2024 at 17:00, 2 years 3 months ago

Dr. Jeffrey Lieberman to Host "Mind-Bending Medicines" SXSW 2024 Meet Up
Clinical neuroscientist Jeffrey A. Lieberman, M.D. will host a thought-provoking SXSW 2024 Meet Up to explore the therapeutic promises and potential perils of mind-bending medicines, including cannabis and psychedelics

Jeffrey A. Lieberman SXSW 2024 Mind-bending Medicines Psychedelics Cannabis
PRESS RELEASE

published on 11/07/2023 at 06:00, 2 years 5 months ago

Dr. Jeffery A. Lieberman, M.D., Best-Selling Author of Malady of the Mind, to Speak at the 2023 Miami Book Fair on Sunday, November 19th

Accesswire

Published on 05/02/2026 at 01:30, 35 minutes ago

Uraniumx Reports Strong Financial Position Ahead of Spring Drill Program
Published on 05/02/2026 at 00:50, 1 hour 15 minutes ago

CoTec Announces Annual Stock Option, Restricted Share Unit And Deferred Share Unit Grants
Published on 05/02/2026 at 00:00, 2 hours 5 minutes ago

Redwood AI Announces Enhanced AI Models, Increasing Evaluated Chemical Reactions Following Preliminary Results from UBC Collaboration
Published on 05/02/2026 at 00:00, 2 hours 5 minutes ago

Onco-Innovations Expands Manufacturing Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services, Advancing Multi-Kilogram Non-GMP Synthesis to Support IND-Enabling Studies
Published on 05/01/2026 at 22:30, 3 hours 35 minutes ago

Nextech3D.ai Appoints New Independent Auditor

View all ACCESSWIRE

EQS Group

Published on 05/01/2026 at 19:23, 6 hours 42 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/01/2026 at 18:40, 7 hours 25 minutes ago

Holding(s) in Company
Published on 05/01/2026 at 17:47, 8 hours 18 minutes ago

Key Figures 30.04.2026
Published on 05/01/2026 at 17:45, 8 hours 20 minutes ago

Burkhalter Group acquires Progressio Holding GmbH and anplaq ag, Tamins (GR)
Published on 05/01/2026 at 17:21, 8 hours 44 minutes ago

Fuller, Smith & Turner PLC: Total Voting Rights and Treasury Shares

Les Echos

Published on 04/30/2026 at 20:00, 1 day 6 hours ago

AMA Corp PLC : FY 2025 Earnings & Q1 2026 Revenue
Published on 04/30/2026 at 19:16, 1 day 6 hours ago

AXA announces the results of its Shareholders' Meeting
Published on 04/30/2026 at 19:00, 1 day 7 hours ago

Capital increase through exercise of subscription rights
Published on 04/30/2026 at 18:10, 1 day 7 hours ago

Minutes of the Combined General Meeting held on April 30, 2026
Published on 04/30/2026 at 18:00, 1 day 8 hours ago

TF1 Q1 2026 results - Press release

View all LES ECHOS COMFI WIRE